Holen Sie sich die Stockscreener-App
1.015
13.25%
-0.155
Handel nachbörslich:
1.76
0.745
+73.40%
Biocardia Inc Aktie (BCDA) Neueste Nachrichten
BCDABioCardia Inc Latest SEC Filings - Finviz
BioCardia (BCDA) CFO granted 60,483 RSUs as stock compensation - Stock Titan
Form 4 Biocardia Inc For: 1 July By Investing.com - Investing.com UK
BioCardia (BCDA) CEO Peter Altman granted 110,625 fully vested RSUs - Stock Titan
BioCardia (BCDA) SVP awarded 39,521 RSUs fully vesting on June 29, 2026 - Stock Titan
BCDA Q1 2026 Earnings: Wider-than-Expected Loss Amid No Revenue, Stock Jumps 10%Debt Analysis Report - dars.gov.et
Price to book forward of BioCardia, Inc. – NASDAQ:BCDA - TradingView
BioCardia, Inc. Actuals & Estimates (NASDAQ:BCDA) - TradingView
BCDA Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of BioCardia, Inc. – NASDAQ:BCDA - TradingView
BioCardia Inc (BCDA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enterprise value to EBITDA forward of BioCardia, Inc. – NASDAQ:BCDA - TradingView
BioCardia director Simon Stertzer buys $103,584 in common stock - Investing.com UK
BioCardia director Simon Stertzer buys $103,584 in common stock By Investing.com - Investing.com South Africa
Form 4 Biocardia Inc For: 24 June By Investing.com - Investing.com Australia
Director Stertzer (BCDA) adds 109,200 BioCardia shares in open-market buys - Stock Titan
BioCardia Inc (BCDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioCardia president & CEO Peter Altman buys $2,043 in stock - Investing.com UK
BioCardia president & CEO Peter Altman buys $2,043 in stock By Investing.com - Investing.com South Africa
Form 4 Biocardia Inc For: 22 June By Investing.com - Investing.com Nigeria
BioCardia (BCDA) CEO adds 2,300 shares in open-market buys - Stock Titan
BioCardia (BCDA) Moves Higher Near Resistance – Testing Key LevelsMomentum Stock Picks - dars.gov.et
BioCardia shares rally after FDA supports regulatory path for heart failure therapy (BCDA) - MSN
BioCardia (BCDA) Shares Strategic Business Update Following Capi - GuruFocus
BioCardia Outlines 2026 Strategic Priorities: Japan CardiAMP Submission, U.S. Expansion, and New Partnership Opportunities – Minichart - Minichart
BioCardia's High-Stakes Gambit: A Japan-First Strategy for Heart Therapy - BriefGlance
symbol__ Stock Quote Price and Forecast - CNN
BioCardia plans Japan regulatory submission for heart therapy By Investing.com - Investing.com South Africa
BioCardia plans Japan regulatory submission for heart therapy - Investing.com
BioCardia Inc (BCDA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioCardia Outlines 2026 CardiAMP Strategy and Milestones - TipRanks
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities - The Manila Times
BioCardia targets Japan PMDA submission for CardiAMP, advances U.S. trial and partnership opportunities - TradingView
BioCardia (NASDAQ: BCDA) details Japan approval push and 2026 catalysts - Stock Titan
BioCardia Inc (BCDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioCardia Inc (BCDA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioCardia Inc (BCDA) Institutional Confidence - TradingKey
BioCardia Inc (BCDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioCardia Inc (BCDA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioCardia Inc (BCDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
1.17%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):